Lombard Odier Asset Management (Usa) Corp Celularity Inc Transaction History

Lombard Odier Asset Management (Usa) Corp

  • $1.47 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 16, 2022
SELL
$3.81 - $9.79 $38,100 - $97,899
-10,000 Reduced 16.67%
50,000 $436,000
Q4 2021

Feb 14, 2022
BUY
$4.64 - $7.46 $92,800 - $149,200
20,000 Added 50.0%
60,000 $307,000
Q3 2021

Nov 12, 2021
BUY
$6.05 - $12.15 $242,000 - $486,000
40,000 New
40,000 $283,000

Others Institutions Holding CELU

# of Institutions
3
Shares Held
23.6M
Call Options Held
0
Put Options Held
0
View Full List

About Celularity Inc

CELU Quotes by TradingView
  • Ticker CELU
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 142,424,000
  • Market Cap $319M
  • Description
  • Celularity Inc., a clinical-stage biotechnology company, develops off-the-shelf placental-derived allogeneic cell therapies for the treatment of cancer, immune, and infectious diseases. It operates through three segments: Cell Therapy, Degenerative Disease, and BioBanking. The company's lead therapeutic programs include CYCART-19, a placental-de...
More about CELU
Track This Portfolio

Track Lombard Odier Asset Management (Usa) Corp Portfolio

Follow Lombard Odier Asset Management (Usa) Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lombard Odier Asset Management (Usa) Corp, based on Form 13F filings with the SEC.

News

Stay updated on Lombard Odier Asset Management (Usa) Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email